Anti-NMI functional antibody

Anti-NMI functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to NMI/NMI products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1126-Ab-1/ GM-Tg-hg-SE1126-Ab-2Anti-Human NMI monoclonal antibodyHuman
GM-Tg-rg-SE1126-Ab-1/ GM-Tg-rg-SE1126-Ab-2Anti-Rat NMI monoclonal antibodyRat
GM-Tg-mg-SE1126-Ab-1/ GM-Tg-mg-SE1126-Ab-2Anti-Mouse NMI monoclonal antibodyMouse
GM-Tg-cynog-SE1126-Ab-1/ GM-Tg-cynog-SE1126-Ab-2Anti-Cynomolgus/ Rhesus macaque NMI monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1126-Ab-1/ GM-Tg-felg-SE1126-Ab-2Anti-Feline NMI monoclonal antibodyFeline
GM-Tg-cang-SE1126-Ab-1/ GM-Tg-cang-SE1126-Ab-2Anti-Canine NMI monoclonal antibodyCanine
GM-Tg-bovg-SE1126-Ab-1/ GM-Tg-bovg-SE1126-Ab-2Anti-Bovine NMI monoclonal antibodyBovine
GM-Tg-equg-SE1126-Ab-1/ GM-Tg-equg-SE1126-Ab-2Anti-Equine NMI monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1126-Ab-1/ GM-Tg-hg-SE1126-Ab-2; GM-Tg-rg-SE1126-Ab-1/ GM-Tg-rg-SE1126-Ab-2;
GM-Tg-mg-SE1126-Ab-1/ GM-Tg-mg-SE1126-Ab-2; GM-Tg-cynog-SE1126-Ab-1/ GM-Tg-cynog-SE1126-Ab-2;
GM-Tg-felg-SE1126-Ab-1/ GM-Tg-felg-SE1126-Ab-2; GM-Tg-cang-SE1126-Ab-1/ GM-Tg-cang-SE1126-Ab-2;
GM-Tg-bovg-SE1126-Ab-1/ GM-Tg-bovg-SE1126-Ab-2; GM-Tg-equg-SE1126-Ab-1/ GM-Tg-equg-SE1126-Ab-2
Products NameAnti-NMI monoclonal antibody
Formatmab
Target NameNMI
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NMI benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1126-Ag-1Recombinant multi-species NMI protein
    ORF Viral VectorpGMLP003879human NMI Lentivirus plasmid
    ORF Viral VectorpGMLP001279human NMI Lentivirus plasmid
    ORF Viral VectorvGMLP003879human NMI Lentivirus particle
    ORF Viral VectorvGMLP001279human NMI Lentivirus particle
    ORF Viral VectorpGMLPm001000mouse Nmi Lentivirus plasmid
    ORF Viral VectorvGMLPm001000mouse Nmi Lentivirus particle


    Target information

    Target IDGM-SE1126
    Target NameNMI
    Gene ID9111,64685,311021,694554,476146,101100404,511280,100050154
    Gene Symbol and SynonymsNMI
    Uniprot AccessionQ13287,Q3ZCL3
    Uniprot Entry NameNMI_HUMAN,NMI_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000123609
    Target ClassificationN/A

    The target: NMI, gene name: NMI, also named as . NMYC interactor (NMI) encodes a protein that interacts with NMYC and CMYC (two members of the oncogene Myc family), and other transcription factors containing a Zip, HLH, or HLH-Zip motif. The NMI protein also interacts with all STATs except STAT2 and augments STAT-mediated transcription in response to cytokines IL2 and IFN-gamma. The NMI mRNA has low expression levels in all human fetal and adult tissues tested except brain and has high expression in cancer cell line-myeloid leukemias. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.